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ABSTRACT 
 
The Effects of Fungal Pigments on Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass 
Spectral Peak Formation 
 
Amanda Dawn Buskirk 
 
 Fungi are ubiquitous microorganisms that commonly cause diseases with high mortality rates in 
immunocompromised hosts. In order to successfully treat the infection and subsequently decrease 
mortality rates, it is necessary to rapidly identify the causal organism(s) and promptly begin the proper 
treatment. Common identification methods, such as viable culture characterization, are often time 
consuming or not species-specific, as is the case with many molecular or immunodiagnostic assays. 
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) has been 
used to discriminate between many clinically relevant microorganisms. Recently, MALDI-TOF MS has 
been used to discriminate between monilaceous fungal species, however, darkly pigmented fungi yield 
poor mass spectra with only a few peaks of low relative abundance. Darkly pigmented fungi are of 
interest because they are common indoor contaminants, and frequently a cause of disease in 
immunocompromised patients. In this study, the effect of dark fungal pigments on the ionization of 
standard peptide and protein solutions during MALDI-TOF MS is investigated. Solutions of human 
serum albumin and angiotensin II were spiked with varying concentrations of both synthetic melanin and 
fungal pigments extracted from Aspergillus niger, A. fumigatus, and A. terreus.  Serum albumin and 
angiotensin II [M+H]+ signals were suppressed in a concentration dependent manner. Examination of the 
MALDI sample deposit under magnification showed significant heterogeneity, with regions of highly 
concentrated pigment appearing black. MALDI-TOF mass spectra acquired from darkly pigmented 
regions of the sample deposit yielded poor or no [M+H]+ ion signal from the standard.  In contrast, non-
pigmented regions within the sample deposit and liquid hyphal negative control extracts of A. niger, A. 
fumigatus, and A. terreus produced no such inhibition.  Gas chromatography analysis of each fungal 
pigment extract revealed the presence of putative cell wall components including aliphatic chains and 
fatty acids. Field emission scanning electron microscopy (FESEM) showed A. niger and A. fumigatus 
extracts retain original spore morphology, while the A. terreus extract was homogeneous and 
morphologically similar to synthetic melanin. This study demonstrates that synthetic and fungal 
pigmentation derived from darkly pigmented fungi inhibits the desorption/ionization process during 
MALDI-TOF MS, however these fungi may be successfully analyzed by MALDI-TOF MS when culture 
methods that suppress pigment expression are employed. 
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Chapter I 
General Introduction/Literature Review 
 
Overview of Fungi 
 Fungi are a diverse kingdom of spore-forming microorganisms. Fungal spores emerge from the 
reproductive structures (e.g.  hyphae and conidial head) of germinating fungi (1). These spores are 
released into the environment upon environmental disturbances including wind, vibrations, humidity, and 
water exposures (2). Because of their small size and aerodynamic nature, these spores may be carried for 
long distances in the wind current until they deposit onto a suitable substrate under appropriate 
environmental conditions. These substrates include nutrients such as carbohydrates, sugars, and high 
water content, with environmental temperatures commonly within the range of 25-37°C. This means that 
fungi can grow on many surfaces especially in indoor environments that are prone to water infiltration, 
contain cellulose-based building materials, and lack adequate ventilation (1, 2). 
 Because of the ability to easily propagate large cultures of fungi,  as well as the ease in 
manipulating the culture conditions to produce desirable products, many fungal products have been 
utilized in industry, agriculture, and pharmaceuticals. Saccharomyces cerevisiae, an ascomycetes yeast, 
has been used in the fermentation process to produce alcohol, yogurt, and bread (3). Several fungi, such as 
members of the genera Aspergillus, Chaetomium, and most commonly known Penicillium, are used to 
produce antimicrobial drugs from metabolites and toxins produced during fungal growth (4). 
Furthermore, mycotoxins from the fungi Aspergillus terreus and Penicillium citrinum have been used to 
produce lovastatin and compactin, respectively, which are drugs used to lower cholesterol in patients (5).  
 Despite the many beneficial uses of fungi, personal exposure to spores, hyphae, and fungal 
fragments can result in adverse health effects such as induction and exacerbation of allergy and asthma, as 
well as causing mycoses or toxicoses in immunocompromised patients (6-9). Eduard et al. reported that 
the total number of spores within contaminated buildings may exceed levels of 107 spores/m3, and those 
spores are commonly inhaled by humans during natural and occupational fungal exposures (2, 10). Health 
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effects occurring in patients following fungal exposures range from fatigue, respiratory symptoms, 
gastrointestinal problems, as well as neurocognitive symptoms, dizziness, and vision problems (11). It has 
been estimated that as much as 10% of the U.S. population has allergy to common fungal agents (11). In 
addition, different climatic regions of the world support varying assemblages of fungal species and the 
concentration of these fungi are dependent upon the season (12). In 2002, it was estimated that in the U.S. 
alone, 10,000 lawsuits related to mold in households were pending in the court systems. Insurance 
companies had paid out over 2 billion dollars in Texas alone due to mold related claims, illustrating the 
economic impact of unwanted fungal growth (11). 
 To date, research efforts have focused on understanding the health effects associated with fungal 
exposures, such as allergic sensitization, toxicoses, invasive infections, and exacerbation of existing 
pulmonary conditions such as allergy and asthma (1, 6-9, 13, 14). Immunocompetent individuals rapidly 
clear inhaled fungal spores and fragments with no damage to the lungs (15). However, in 
immunosuppressed, neutropenic individuals, fungi can begin to germinate within 6-8 hours after exposure 
(1, 16). Once the fungus begins to grow within the airways of these patients, invasive infection most 
commonly ensues and is associated with high mortality rates ranging between 50-99%, even after strong 
antifungal treatments (1, 11, 16). Due to increasing numbers of immunosuppressed patients, fungal 
infections have placed a significant economic burden on health care. Invasive aspergillosis (IA), most 
commonly caused by Aspergillus fumigatus, is one of the predominant diseases associated with 
immunocompromised patients. It was reported to occur in 17-26% of patients after lung transplants, 5-
15% after allogenic bone marrow transplants, 5-24% of those with acute leukemia, and 2-13% of patients 
after heart transplants in the U.S. (11).  The average age of patients with invasive aspergillosis is 53 years 
old, and 58% of patients are men. In 1996 alone, there were over 10,000 hospitalizations for invasive 
aspergillosis, with greater than 19% mortality in those individuals. These cases resulted in over 170,000 
days of hospitalization, costing the U.S. over 630 million dollars, further illustrating the economic burden 
of fungal exposures (11). 
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Methods of Fungal Identification 
 Successful treatment of fungal infections is dependent upon rapid identification of the causal 
fungus followed by the administration of appropriate antifungal agents (17, 18). Samples must first be 
obtained from the patient to identify the causal organism(s) and may be obtained from the tissue, 
blood/serum, bronchoalveolar lavage fluid (BAL), or cerebrospinal fluid (CSF). Obtaining tissue samples 
or biopsies from a patient that is immunosuppressed is an invasive procedure that may be detrimental to 
the patient, thus this method is often avoided. Therefore, fluids are most commonly used to determine the 
contaminating organism(s). Viable culture is the most widely used method for identifying fungal 
infections from the patient (19). This method involves culturing the causal fungus on differential media 
selective for specific fungi and then macro and microscopic examination of the culture by a trained 
mycologist. Morphology, hyphal fragmentation, colony color, and spore emergence from the hyphae are 
colony characteristics that can be used to identify fungal colonies. Major drawbacks with these 
identification methods are that the laboratory requires a trained mycologist and a long culture incubation 
time (24-72 hours for most fungi, with some requiring weeks for growth). Further, many fungi may have 
similar morphological characteristics that may lead to misidentification (20).  
 While the 'gold standard' for positive fungal identification in clinical samples commonly requires 
positive culture identification, as well as visualization of fungal masses via chest x-rays, computer 
tomography (CT scans), or magnetic resonance imaging (MRI), other techniques have also been used to 
in conjunction with these methods (1, 19). Most of these are immunoassays or enzyme-linked 
immunosorbent assays (ELISAs), which use monoclonal and polyclonal antibodies that have been 
developed for detecting fungal components or metabolites that may be present in the serum of the patient. 
In these cases serum is tested by direct or indirect immunoassay formats for the presence of previously 
identified and characterized antigens isolated from a number of known fungal pathogens (21-26). Some 
common monoclonal antibodies include those against β-glucans, ergesterol, glycoproteins, mannans, or 
other cell wall components. In addition, putative diagnostic markers have been identified for species-
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specific antigenic proteins in common fungal pathogens, such as Asp f 1 from Aspergillus fumigatus, the 
causal organism of IA (27, 28). 
 Since IA is a disease primarily associated with immunosuppressed patients, and is associated with 
high mortality rates, it is of major concern in the medical community. IA is difficult to diagnose in the 
early stages, however, at later stages antifungal therapy often fails resulting in mortality rates as high as 
99% (1, 11, 29, 30). There are two commercially available immunoassays for Aspergillus identification, 
both with varying specificity and sensitivity. These assays, the Platelia Aspergillus enzyme immunoassay 
and the Pastorex Aspergillus latex agglutination test, detect galactomannan, a carbohydrate cell wall 
component, associated with Aspergillus, and utilize the same rat monoclonal antibody, EBA-2 (26). In the 
Pastorex assay, latex beads are coated with the EBA-2 antibody and the patient serum is added to the 
beads. If the sample is positive for galactomannan, then the beads will agglutinate. The Platelia assay is a 
sandwich ELISA, in which a 96-well polystyrene plate is first coated with the EBA-2 antibody, the 
patient serum is added, and an enzyme-linked EBA-2 detection antibody is added to the well. Specific 
substrate for the enzyme-linked detection antibody is then added to the well and a color change is 
observed in a positive sample (22). Both of these techniques can yield a false positive if the patient has 
been treated with β-lactam antibiotics. These antibiotics are isolated from Penicillium, and because the 
EBA-2 antibody specifically recognizes the (15)-β-D-galactofuranoside side chains of the 
galactomannan moiety, which are found in Aspergillus, Penicillium, and Paecilomycese fungi, false 
positives may occur. A false positive may also arise if the origin of the patient infection is from 
Penicillium or Paecilomycese for the same reason (21, 30, 31). 
 
Therefore, these assays are limited to only 
identifying known antigens. Patient samples containing antigens from an unknown pathogen may also 
result in false negatives. Though ELISAs can be completed rapidly in comparison to viable culture and 
morphological characterization, many of the antibodies developed to date are not species-specific. 
Therefore, despite the possibility of rapidly identifying the presence of fungus in the patient sample, more 
species-specificity is needed.  
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 Polymerase Chain Reaction (PCR) is a molecular technique that has recently been used for 
detecting pathogenic and non-pathogenic fungi. This method involves using commercially available 
primers directed toward common sequences within the fungal genome, typically from the 18S rRNA 
subunit, though others, such as primers directed towards the genes encoding ergosterol, β-glucans, β-
tubulin, or other cell wall components may also be used (19, 32). The latter primers can identify a positive 
fungal infection but are not species-specific, as many cell wall components are conserved in most fungi, 
regardless of the species origin (32). Internal transcribed spacer regions (ITS regions) are also targets for 
PCR amplification, as they are often conserved among species (19, 32). Primers directed toward the ITS 
regions are species-specific in most cases, offering as high as 98% identification, with low levels of false 
positives (19). Real-time PCR for fungal identification has also been used. This technique offers the 
ability to quantitate the number of fungal specific gene copies, which has been proposed to be correlated 
to disease progression. This information would be invaluable for disease prognosis, as well as for 
identifying the proper course of prophylactics to use for the best patient outcome (19). 
  Though PCR offers increased sensitivity for fungal identification, approaching 100% sensitivity 
and specificity when done in conjunction with other methods, there are many drawbacks to this technique 
(23, 24). The major issues surrounding PCR for fungal identification are the ubiquitous nature of fungi. 
Fungi may contaminate samples at the isolation stage, DNA extraction stage, the sample PCR preparation 
stage, as well as cross-contamination between PCR runs, and therefore are common areas yielding false 
positives. The presence of fungal components in the DNA extraction solutions, many of which may 
contain enzymes that have been isolated from different fungi, may also be a source for false positives. 
Also, many of these solutions are not compatible with common methods for fungal decontamination, such 
as UV irradiation, phenol precipitation, or filtration (32). Although using PCR using primers directed 
toward the rRNA subunits can detect the target from a fraction of one organism, interference with the 
larger amounts of human DNA in the patient samples has been reported. Some of the primers may interact 
with human DNA, preventing the fungal target from being amplified in high enough amounts to be 
analyzed. Furthermore, molecular techniques have not been standardized and have only recently been 
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realized by the Minimum Information for Publication of Quantitative Real-Time PCR Experiments 
(MIQE) guidelines (26, 32). 
 Commercially available nucleic acid hybridization probes have also been employed for fungal 
identification (19, 33). In this method, species-specific chemiluminescent single stranded DNA probes are 
bound to a chip, the organism is cultured and a small amount removed and lysed to release the nucleic 
acids, which are then denatured and added to the chip. The complementary ribosomal RNA released from 
the isolated fungus will then hybridize to the probes and activate the chemiluminescence. The degree of 
hybridization can be measured in relative light units using a luminometer. This technique has high 
sensitivity and specificity for certain fungi tested, such as Blastomyces dermatitidis, Histoplasma 
capsulatum, and Coccidiodes immitis, however, cross reactivity with the B. dermatitidis probe has been 
reported (19). Despite the potential of this technique, the lack of species-specific DNA probes highlights a 
major drawback in the field of fungal research. Over 70,000 fungal species have been identified, and over 
1.5 million species are thought to exist; however, only a fraction of these fungi have been sequenced (34, 
35). Further research needs to be completed with this technique to further identify species-specific probes, 
as well as to increase the commercial availability to realize the potential of this method. 
 
MALDI-TOF MS 
 Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) 
is a more recent analytical method that can be used to identify an analyte present in a sample, and has 
been used to discriminate between clinically relevant microorganisms (36, 37). MALDI is a specific type 
of ionization method for mass spectrometry that utilizes samples mixed with a matrix, or an H+ donor 
which co-crystallizes with the sample on a target chip. Commonly, the target chip is made of an electrical 
conductor, such as stainless steel or gold (38). Once the sample is loaded into the mass spectrometer, a 
UV laser (commonly 337-nm N2 or 355-nm Nd:YAG) is fired at the sample spot. Upon laser excitation of 
the sample, matrix and co-crystallized analyte are desorbed in a supersonic plume of ions and neutrals 
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into the gas phase in the vacuum of the mass spectrometer where transfer of protons from the sample 
matrix to the analyte occurs (39, 40).  
 Time-of-flight mass spectrometry (TOF MS) is the method used for detecting and analyzing 
samples (41, 42). There is a short source region near the sample plume, which consists of a backing plate 
and an extraction grid. Upon laser excitation of the sample, the potential energy (PE) of the short source 
region is zero. A positive voltage is then applied to the backing plate, creating an electric field, thereby 
increasing the PE "behind" the sample. Ions are accelerated to a constant kinetic energy by the high 
electrical potential (typically as high as 20kV) into a vacuum tube, or field-free drift region. A vacuum 
tube is used to lessen the potential for collisions within the field free region, as such interactions may alter 
the velocity of the ions, thereby altering mass resolution of the ions. Mass resolution is the ability to 
distinguish between peaks within a spectrum based on analyte peak widths as well as relative separation 
of peaks. The analytes travel through the vacuum tube at a rate that is proportional to their mass to charge 
ratio, i.e. larger, heavier molecules will travel slower than smaller, lighter molecules, while an increase in 
the number of charges on an ion will allow it to travel faster than an ion with fewer charges. The ions then 
impact a detector at the end of the vacuum tube, creating a cascade of electrons which are amplified and 
detected as electrical current (41, 42). The spectra are recorded based on mass/charge (m/z) and the 
relative abundance of the analyte (proportional to the number of hits reaching the detector at a specific 
m/z). Therefore, most protein-containing samples can be analyzed if the protein content is above that of 
the detectable limit of the instrument. Each protein mixture yields a spectrum that is representative of the 
molecules within the sample and is unique to individual analytes. 
 
Microbial Discrimination/Identification using MALDI-TOF MS  
 MALDI-TOF MS has been widely used for the discrimination and identification of numerous 
microbes because the spectra produced by MALDI-TOF MS analysis are unique to each microbe, 
synonymous to a human fingerprint. Thus, these spectra are referred to as microbial “fingerprints”.  The 
majority of experiments done using MALDI-TOF MS for the discrimination of microbes have focused on 
 8
bacterial fingerprinting. In 1994, the first experiment using MALDI-TOF MS for bacterial discrimination 
was able to detect water soluble surface proteins of bacteria, which allowed for the differentiation 
between gram positive and gram negative organisms (43). Further studies were done to show the ability 
of MALDI-TOF MS to distinguish between multiple organisms of different species using whole cell 
bacterial preparations to obtain unique fingerprints for each bacterium (44-46). Briefly, a small aliquot of 
bacteria were placed on a target spot, allowed to air dry, and then overlaid with matrix before analyzing 
with the mass spectrometer. Using this technique, many clinically relevant bacteria have been analyzed, 
including Escherichia coli, Pseudomonas (45), Staphylococcus, Mycobacterium (44), and Bacillus 
anthracis (46). The ability to differentiate these organisms is due to the presence of unique ions at 
different m/z ranges for each species. A complete list of bacteria which have been analyzed using 
MALDI-TOF MS is shown in a recent publication by Giebel et al. and includes 22 clinically relevant 
bacterial genera (47).  
 MALDI-TOF MS has also been used to differentiate between different strains of the same 
organism (48, 49). For example, this technique has been useful in discriminating between pathogenic, 
multi-drug resistant strains of normal microbiota, such as Staphylococcus and methicillin resistant 
Staphylococcus aureus (MRSA) (48). In this study, each strain yielded a unique distinct spectrum, 
however, when analyzing large numbers of clinical isolates and laboratory strains, the authors state that a 
distinctive spectrum representative of MRSA could not be obtained. The authors noted, however, that the 
MRSA strains could be differentiated from each other, and this could be used to identify the origin of 
clonal strains. 
 Several studies have focused on the use of MALDI-TOF MS for bacterial identification in clinical 
laboratories (50-54). In these studies, bacteria had been recovered from blood, cerebrospinal fluid (CSF), 
pus, biopsy, the respiratory tract, stool, and wounds. Samples were identified using standard phenotypical 
methodology by using differential growth mediums and conditions. In parallel, a single colony of the 
bacterium were deposited on a MALDI-TOF MS target plate and overlaid with matrix and then analyzed. 
(53). Of the 1660 isolates, from 45 genera and 109 species obtained, MALDI-TOF MS was able to 
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correctly identify 95.5% of the organisms, the same as done by standard routine identification, with 
84.1% of the samples being identified at the species level. Forty-six of the isolates were unable to be 
fingerprinted using MALDI-TOF MS, however, this number was not statistically different from the 
standard routine identification methods, which failed to identify thirty-two of the isolates. Furthermore, 
this study reported that the lack of identification by MALDI-TOF MS was related to the lack of reference 
spectra for comparison of those species. For example, for the bacterial species that contained more than 5 
reference spectra, greater than 85% of those bacterial species were identified using MALDI-TOF MS. 
This highlights the importance of having a large database library for direct comparison of unknown 
samples. The authors also reported a cost/time of identification comparison analysis, whereby they 
compared the standard protocols for bacterial identification with MALDI-TOF MS discriminate analysis. 
They reported that mass spectrometry identification took approximately 8.5 minutes and cost 1.43 
euros/sample. When compared to gram staining, which takes 6 minutes and costs 0.6 euros/sample, API 
system identification which takes 1080-2880 minutes and costs 4.6-6.0 euros/sample, antibiotic 
susceptibility testing which takes 1080-2880 minutes and costs 6.6-7.4 euros/sample, Phoenix system 
identification and susceptibility testing which takes 300-1200 minutes and costs 12.65 euros/sample, and 
the Vitek system which takes 300-480 minutes for identification and costs 5.9-8.23 euros/sample and in 
conjunction with susceptibility testing costs 10.38-12.71 euros/sample, MALDI-TOF MS is the most cost 
and time efficient method for comparable bacterial identification (53). 
 Further studies have examined the potential use of MALDI-TOF MS for bacterial identification 
in positive blood cultures. In a study done by Christner et al., 304 positive blood cultures (reported 
positive by an automated incubation system), of which 277 contained a single bacterium, were analyzed 
using MALDI-TOF MS fingerprinting (51). The authors report 95% correct bacterial identification, with 
94% of those samples being identifiable on the same day as the blood samples showed positive culture. 
Another study of 1,371 isolates obtained from clinical samples were identified using conventional 
methods and analyzed via MALDI-TOF MS in parallel, reported 95.1% correct identification rate. In this 
study 63 isolates were unable to be identified, however, the authors reported possible reasons for the 
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misidentification/inability to identify as being initial conventional misidentification in 7 isolates, and the 
remaining 56 isolates were predominantly misidentified as a result of human error in taxonomic 
assignment of the reference spectra in the database, recent changes in taxonomy of a given species, or 
different levels of precision in identification between conventional identification methods and MALDI-
TOF MS (50). A study done in 2010 reported 95.1% correct species identification of 327 isolates taken 
from blood, pus, respiratory tract, stool, wounds, CSF, and urine (54).  
 Another study, which focused on bacterial identification in positive blood cultures,  reported  the 
ability of MALDI-TOF MS to identify false positives (as labeled positive by standard conventional 
protocols), and reported 83.3% species level identification of gram-negative bacteria, 96.6% genus level 
in a sample population of 318 positive blood cultures (47, 52). In gram-positive bacteria, species 
identification was 31.8% and 65.7% at the genus level when compared to conventional methods. The 
comparable difference between identification in gram-positive and gram-negative bacteria may be due to 
the sample processing done by the authors, as there were multiple wash steps before analysis. Further, 
gram-positive bacteria have a thicker cell wall, which strongly binds surface proteins and may be harder 
to lyse. Therefore, the amount of protein obtained from gram-positive bacteria may have been lower than 
that obtained from the gram-negative bacteria which may have lysed during the washing steps. These are 
speculations, as the authors did not report sample extraction optimization.  
 As shown by Hettick et al., bacterial samples with thicker cell walls, such as Mycobacterium spp., 
are sufficiently discriminated from each other when harsher protein extraction steps are used for sample 
preparation (55). In this study, several different species of  Mycobacterium, including M. fortuitum, M. 
kansasii, M. intracellulare, M. avium, M. bovis BCG, and M. tuberculosis H37Ra, were subjected 
organic/acid extraction and analyzed via MALDI-TOF MS. Using linear discriminant analysis of 77 
peaks identified among all species of the sample, 100% of the spectra were correctly identified. 
 In addition to fingerprinting and discriminating bacteria, MALDI-TOF MS has been used to 
identify the presence of viruses. Because the standard methodology for viral identification is relatively 
quick and has a low false identification rate, MALDI-TOF MS has not been as extensively examined as 
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an alternative method of viral identification, but has been used for detection. Specifically, 6 different 
viruses have been fingerprinted including, Heptatitis B and C, Norovirus, Avian influenza viruses, 
Newcastle disease virus, and the Sindbis virus (47). Commonly, specific proteins or peptides are targeted 
for specific viral identification. These include the capsid protein (56), fusion proteins (57, 58), and 
glycoproteins associated with the viral envelope (59). In addition, DNA has also been used to specifically 
identify some viruses, including determining the molecular weight of specific restriction fragments from 
complementary DNA (60-62). 
 
Limitations of MALDI-TOF MS Microbial Fingerprinting 
 Though multiple studies have demonstrated the ability of MALDI-TOF MS to discriminate 
between numerous clinically relevant microbes, there are also several limitations to this technique. The 
major limitation is the reference library or database (53). In order to correctly identify clinical pathogens 
by MALDI-TOF MS, a representative comparison spectrum must be present in the database. If no 
reference spectrum is present to compare the sample spectrum to, then no identification can be made. This 
limitation is not one of the instrument, but rather of the compiled database. Therefore, a large, extensive 
database of all clinically relevant organisms must be compiled for MALDI-TOF MS to correctly identify 
or discriminate the clinical organism. 
 In addition, the culture conditions may alter the spectrum of the sample organism when compared 
to the database. The length of time the culture is grown, as well as the temperature, and the culture 
medium have been shown to alter the protein content of many microbes (63). The method for protein 
extraction, where applicable, may also alter the proteins present in the sample. Though intact cell mass 
spectrometry may not be altered by protein extraction protocols, results from our laboratory show that 
bead beating samples, both bacterial (Mycobacterium) and fungi (Aspergillus and Penicillium), increase 
the number of peaks in a spectrum, presumably due to the release of intracellular proteins due to bead 
beating (49, 64, 65). In addition, the choice of solvent used for the elution of extracellular proteins must 
be kept uniform, as different proteins may or may not solubilize in the presence of different organic 
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and/or acidic solvents. Therefore, samples comprising the reference database must be treated in the same 
manner as the unknown sample in order to accurately identify the unknown microbe.  
Furthermore, studies have shown that a minimum of 1 x 104  microbial cells must be present 
within the sample to yield a spectrum with an adequate number of peaks with a high enough relative 
abundance above the background noise (66). The number of required microbial cells may differ between 
each individual mass spectrometer used, as each commercially available instrument has differing 
sensitivities, as well as between microorganisms, as the concentration of soluble proteins may differ 
between species.  
 Another limitation of MALDI-TOF MS is the reproducibility of the technique. Reproducibility 
within a laboratory is often very high (75% and higher) (48, 67-70), however, when the same samples are 
sent to other laboratories for the same analysis, the reproducibility may decline (as low as 23%) (71).  The 
lack of reproducibility between laboratories is attributed to the differences in sensitivity of the different 
mass spectrometers used in each different laboratory. To address this issue, many mass spectrometer 
companies have been designing 'biotypers', which are essentially mass spectrometers that use a 
commercial database consisting of a library of spectra from common microorganisms for reference and 
discrimination (72). These instruments can be used to identify pathogenic organisms from human samples 
within hours.  
   
MALDI-TOF MS Fingerprinting of Fungi 
 MALDI-TOF MS has been used to fingerprint and discriminate between fungi. Fourteen 
medically important fungal genera have been fingerprinted to date. The first study to fingerprint fungi was 
published in 2000, where various species of Penicillium, as well as Scytalidum dimidiatum and 
Trichophyton rubrum were characterized. In most studies examining the fingerprints of fungi, methods to 
lyse the spores of fungi are used to obtain a fingerprint with a greater number of peaks/ increased relative 
abundance (64, 65, 73). These methods include acidic lysing, as done with Saccharomyces cerevisiae 
(74), or bead beating in an organic/acidic solvent, as done with several species of Aspergillus and 
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Penicillium (64, 65).  In the studies done by Hettick et al., MALDI-TOF MS was able to discriminate 
between 12 species of Penicillium and 12 species of Aspergillus with a 0% error rate using discriminant 
analysis. MALDI-TOF MS was also able to correctly discriminate between 5 different strains of A. flavus 
95% of the time.   
Several studies have demonstrated the utility of MALDI-TOF MS for fingerprint profiling of 
multiple species of fungi; however, one limitation has been identified by several groups (64, 73, 75). 
Darkly pigmented fungi, such as Aspergillus niger, Stachybotrys chartarum, and Alternaria alternata 
could not be fingerprinted using this technique. These samples produce a mass spectrum containing a 
paucity of distinct peaks preventing identification. Many factors may explain the difficulty in analyzing 
these darkly pigmented fungi. Although the precise mechanism(s) by which the MALDI 
desorption/ionization event occurs is the subject of much discussion and active research (39), it is possible 
that the unique properties of fungal pigments could interfere in a number of fundamental ways with the 
MALDI process. One plausible explanation for the observed inhibition of MALDI-TOF ionization is that 
melanin in fungal samples (particularly at high concentrations) directly competes with the organic acid 
matrix for irradiating photons. Following the MALDI laser pulse, ionization in the dense plume above the 
sample deposit will only occur where there is a sufficient population of electronically excited matrix 
molecules. If a photoexcitation/pooling mechanism for MALDI is assumed (76), mobile excitons in the 
bulk sample deposit could be quenched by fungal pigments.  
 
Fungal Pigmentation 
Darkly pigmented fungi are dark in color because of the high levels of intracellular pigment. 
Fungi are common plant pathogens, and therefore produce pigmentation to protect themselves from 
environmental stresses such as ultraviolet light, as well as to aid in the buildup of turgor pressure which 
the fungi use to penetrate plant tissues (77-79). In submerged conditions, however, most fungi do not 
produce pigments, presumably because the nutritional needs are altered in these environments and the 
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stresses necessary to induce pigment formation are not induced (29). The most common pigment 
associated with fungi is melanin (78, 79). 
 Melanin is a large, complex macromolecule that is formed through the oxidation of phenolic or 
indolic compounds. Typically, melanins appear black, brown, or green in color (79, 80). Several types of 
melanins have been identified (Table 1) (78, 79). Each type of melanin is produced through the 
polymerization of different biomolecules, and thus potentially different biosynthetic pathways (79). 
Phaeomelanins are derived from tyrosine and cysteine, allomelanins are formed from nitrogen-free 
precursors, and eumelanins are a product of the polymerization of tyrosine, quinones, and free radicals 
(Table 1) (80). The predominant types of melanin found in fungi are phaeomelanins and eumelanins. In 
many pathogenic fungi, eumelanins are the most common form of melanin present, though multiple types 
of melanin may exist simultaneously (78-82). There are also two different associated forms of melanin, 
including cell-associated or vesicle-associated melanins (78). Commonly, in darkly pigmented fungi, the 
melanins produced are intercalated within the spore wall of the organism and help to provide stability and 
strength to the spore wall coating. These melanins are covalently bound to carbohydrates and lipids that 
make up the cell wall (16, 78). 
 The exact structure of melanin has not been identified due to the properties of this macromolecule 
which make it difficult to use common biochemical analyses. These properties include: insolubility in 
organic or aqueous solvents, resistance to degradation by strong acids and alkaline agents, and resistance 
to bleaching by strong oxidizing agents. Melanins are negatively charged and hydrophobic (78, 80, 82, 
83). More importantly, fungal melanins have photoprotective properties whereby they absorb UV light 
and dissipate it as heat (84-86). This specific property may be at least partially responsible for the 
inability to acquire unique fingerprints in darkly pigmented fungi. Therefore, it is being hypothesized that 
the presence of dark pigmentation in darkly pigmented fungi prevents proper ionization of the 
proteins/peptides (analytes) within the sample preparation, thereby inhibiting peak formation within the 
spectrum. 
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Fungal Melanins 
Types of fungal melanins Chemical metabolism Color 
Family 
Occurrence Ref. 
Eumelanin 
formed through the 
polymerization of 
tyrosine, quinones, and 
free radicals 
Black, 
dark 
green, 
dark 
brown 
Various fungi (78, 80, 84) 
L-3,4-
Dihydroxyphenylalanine 
(DOPA) 
a subtype of eumelanin ----- -------- (78) 
Phaeomelanin 
formed through the 
polymerization of 
tyrosine, cysteine, and 
dihydroxyphenylalanine 
(DOPA) 
Red, 
yellow Various fungi (78, 80) 
Allomelanin formed from nitrogen-free precursors 
Black, 
brown Various fungi (80, 87) 
Catechol 
a subtype of allomelanin 
formed through phenol 
oxidation of catechol 
Black, 
dark 
brown 
Basidiomycetes (78, 87) 
1,8-
Dihydroxynapthalene 
(DHN) 
formed from acetyl 
coenzyme A and malonyl 
coenzyme A in the 
pentaketide biosynthesis 
pathway 
Black, 
dark 
green, 
dark 
brown 
Ascomycetes, 
Ascomycetous 
imperfecti 
fungi, and 
Dithideaceous 
species 
(78) 
γ-glutaminyl-3,4-
dihydroxybenzene 
formed through oxidation 
of γ-glutaminyl-4-
hydroxybenzene in 
shikimic acid pathway 
Black, 
dark 
brown 
Basidiomycetes (78, 88) 
 
Table 1: Common types of fungal melanins. 
 
Melanin Production 
Eumelanins are divided into subgroups including L-3,4-dihydroxyphenylalanine (L-DOPA) 
melanin and 1,8-dihydroxynapthalene (DHN) melanins (77). Both types of melanin have been identified 
in fungi, and may exist within the same organism. Though multiple types of melanins are associated with 
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fungi, it has been reported that the predominant forms of fungal-associated melanins are DHN-melanins 
(89). The DHN-melanin synthesis pathway begins with glucose, a common sugar which is used by cells 
in the citric acid cycle (TCA). Before entering the TCA cycle one molecule of glucose is converted into 
fructose 6-phosphate, followed by conversion into one molecule of fructose-1,6-diphosphate. This is then 
converted into glyceraldehyde-3-phosphate and then pyruvate (Figure 1). Pyruvate is converted into two 
molecules of acetyl coenzyme A (acetyl-CoA) which is the initial molecule for the pentaketide synthesis 
pathway. In this pathway, acetyl-CoA is converted into 1,3,6,8-4-hydroxynapthalene (1,3,6,8-4HN). A 
tetrahydroxynapthalene reductase then converts 1,3,6,8-4-hydroxynapthalene into scytalone. Tricyclazole, 
an antifungal agent, can block the activity of this reductase producing a shunted pigmented byproduct 
called flaviolin. Following conversion to scytalone, a trihydroxynapthalene reductase converts scytalone 
into vermelone. Again, this conversion may be specifically blocked by tricyclazole, producing another 
shunted pigmented byproduct called 2-hydroxyjugalone. Vermelone is then converted by an unknown 
convertase into dihydroxynapthalene (DHN) which then is polymerized to produce DHN-melanin (90). 
Thus, it is being hypothesized that  due to the electro- and biochemical nature of melanins present in 
darkly pigmented fungi, specifically DHN-melanins and/or DHN-melanin-like pigments, are interfering 
with the proper ionization of the analytes present in the MALDI-TOF MS sample, thereby inhibiting the 
formation of unique, discriminate fingerprint spectra from these species. 
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Figure 1: Dihydroxynapthalene melanin (DHN-melanin) production pathway. Figure adapted from Lee 
et al. (90). 
 
 In this study, it is shown that synthetic melanin, as well as fungal pigment extracts from 
Aspergillus niger, A. fumigatus, and A. terreus, inhibit MALDI-TOF MS analysis of the 66,000 m/z peak 
formation of human serum albumin in a concentration dependent manner. Additionally, heavily 
pigmented areas within a MALDI-TOF target spot directly inhibit mass spectral formation when 
compared to an area within the same spot that contains less pigment. Finally, when darkly pigmented 
fungi, such as A. niger, are cultured under conditions that inhibit pigment formation, a unique fingerprint 
spectrum is obtained using MALDI-TOF MS.  
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Chapter II 
Materials and Methods 
 
Reagents 
Acetonitrile (ACN) (HPLC grade), sodium citrate, and hydrochloric acid (6N) were acquired 
from Fisher Scientific (Fairlawn, NJ). Tricyclazole was acquired from Wako Pure Chemical Industries, 
Ltd. (Osaka, Japan). Malt extract agar (MEA) was acquired from Difco (Sparks, MD). Deionized water 
(DDI) was produced with a Synthesis A-10 (Millipore, Billerica, MA).  All other reagents were acquired 
from Sigma Aldrich (St. Louis, MO) and all reagents were used without further purification. 
 
Fungal Culture 
Fungal isolates were obtained from either the American Type Culture Collection (ATCC, 
Manassas, VA) or the Fungal Genetics Stock Center (FGSC, Kansas City, MO).  Aspergillus terreus 
(ATCC 1012), A. fumigatus (AF293; FGSC A1100) and A. niger (FGSC A1143) were subcultured from 
stock sources and grown for 7 or 14 days at 25°C on malt extract agar (MEA) nutrient media in 100 mm 
culture plates. To ensure reproducibility, each fungal species was cultured eight times independently. 
For submerged culture preparation, approximately 1 X 102 spores were inoculated into 50 mL of 
malt extract broth (MEB) and grown for 4 days in a C24KC refrigerated incubator shaker (Edison, NJ) at 
25°C. Cultures were transferred to 50 mL conical tubes and centrifuged at 41 x g for 5 minutes. The 
supernatant was retained and frozen at -80°C. The mycelial mass was washed 3 times with phosphate 
buffered saline (PBS) to remove residual MEB and forced through a 70 µm mesh filter (BD, Bedford, 
MA) using a syringe plunger in 20 mL of PBS. This solution was centrifuged at 41 x g for 5 minutes and 
the supernatant collected, lyophilized and the dry weight recorded for quantification. The resulting dry 
mass was suspended in 1 mL of ACN/4%TFA (50:50). To ensure reproducibility, each fungal species was 
cultured eight times independently. For tricyclazole mediated melanin inhibition, cultures were grown for 
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7 or 14 days at 25°C on MEA plates supplemented with 50 µg/ml of tricyclazole in 1% ethanol.  To 
ensure reproducibility, each fungal species was cultured eight times independently. 
 
Preparation of Fungal Culture Samples for MALDI-TOF MS Analysis 
Conidia and hyphae derived from one culture plate of A. terreus, A. fumigatus, and A. niger (~108 
spores/mL) were transferred to 100 µL of 0.1 mm zirconium beads (Biospec, Bartlesville, OK, USA) and 
1 mL of ACN/4% trifluroacetic acid (TFA) (50:50). The samples were then subjected to three-one minute 
bead beating cycles.  Samples were cooled on ice between bead beating cycles.  The resulting solution 
was centrifuged at 21,600 x g for ten minutes, and the supernatant fluid retained. A 10 µL aliquot of 
supernatant fluid was combined with 10 µL of α-cyano-4-hydroxycinnamic acid (CHCA, 10 mg/mL) in 
50/50 ACN/0.1% TFA and duplicate 1.5 µL aliquots were deposited on a gold sample stage (Bio-Rad, 
Hercules, CA) and allowed to air dry prior to MALDI-TOF MS analysis.  
 
Preparation of Synthetic Melanin Samples for MALDI-TOF MS Analysis 
Samples were prepared by dissolving varying concentrations of synthetic melanin over the range 
of 0.001 mg/mL to 20 mg/mL in 50/50 ACN/DDI. A 10 µL aliquot of synthetic melanin solution was 
combined with an equal volume of either human serum albumin (7.5 pmol/µL) or angiotensin II (10 
pmol/µL).  A 10 µL aliquot of the resultant mixture was combined with 10 µL of CHCA (10 mg/mL in 
50/50 ACN/0.1% TFA and duplicate 1.5 µL aliquots were deposited on a gold sample stage (Bio-Rad, 
Hercules, CA) and allowed to air dry prior to MALDI-TOF MS analysis. 
 
Isolation of Melanin Ghosts 
So called “melanin ghosts” were extracted from A. terreus, A. fumigatus, and A. niger using a 
method modified from Wang et al. (91). Briefly, cultures were grown on MEA for 10 days at 25°C. 
Sporulating fungal cultures were harvested from the culture plate using sterilized DDI and the resulting 
suspension was centrifuged at 1000 x g for 10 minutes. The pellet was resuspended in 0.1 M sodium 
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citrate buffer containing 10 mg/mL of cell lysing enzymes from T. harzianum and 2 mg/mL cellulase 
from T. reesei and incubated with agitation overnight with at 30ºC. The sample was then pelleted by 
centrifugation (1000 x g for 10 minutes), washed with PBS and resuspended in 4 M guanidine 
isothiocyanate and incubated at room temperature (RT) overnight with agitation. The sample was then 
pelleted, washed with PBS and resuspended in 1 mg/mL of proteinase K in DDI and incubated overnight 
at 37ºC with agitation. The sample was pelleted, washed with PBS and resuspended in 6 M HCl and 
boiled for one hour. The sample was then pelleted, washed with PBS and dialyzed against DDI for 10 
days at 4ºC using 3500 molecular weight cutoff (MWCO) dialysis membrane tubing (Spectra/Por®, 
Laguna Hills, CA). The sample was lyophilized and the resulting melanin ghosts used for further 
experiments. 
Melanin ghosts from each Aspergillus species were diluted with ACN/4% TFA and mixed with 
an equal volume of 7.5 pmol/µL HSA. A 10 µL aliquot of the resulting solution was mixed with 10 µL of 
10 mg/mL CHCA and 1.5 µL deposited on a gold sample stage (Bio-Rad, Hercules, CA) and allowed to 
air dry. Each sample was spotted in duplicate. 
 
UV Spectroscopy 
 Spectrophotometric characterization of melanin was carried out using a Beckman DU 800 
Spectrophotometer (Fullerton, CA) equipped with a deuterium (UV) and a tungsten (Vis) lamp. Data 
acquisition and processing was carried out using the DU800 Spectrometer software. The analytical 
wavelength range was 200 to 800 nm. Temperature control was achieved by using a VWR Scientific 
(Niles, IL) circulating water bath.  Fungal pigments were dissolved in 50/50 HNO3/HF solution with 
sonication for 5 min. Blanking of the instrument was performed with 50/50 HNO3/HF before absorbance 
readings of the melanin were taken. 
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Gas Chromatography/Mass Spectrometry 
Samples were analyzed using an Agilent 6890 gas chromatograph coupled to an Agilent 5975C 
mass spectrometer (MS) using a 30 m HP5-MS column (Agilent Technologies, Santa Clara, CA). 
Samples were injected (1 µL) at a 20:1 split injection ratio into a 300°C inlet. Analytes were eluted from 
the column using 1.0 mL/min helium and an oven temperature profile as follows: 50°C for 5.0 min then 
ramped at 5.0°C/min to a final temperature of 300°C. The MS source temperature was maintained at 
230°C, the quadrupole temperature was maintained at 150°C.   
 
Field Emission Scanning Electron Microscopy 
 A small aliquot of lyophilized extracted pigment was deposited on double-stick carbon tape on an 
aluminum mount and sputter coated with gold/palladium. Images were collected on a Hitachi (Tokyo, 
Japan) S-4800 field emission scanning electron microscope. 
 
MALDI-TOF MS Analysis 
Protein MALDI-TOF mass spectra were acquired using a Ciphergen PBS-IIc linear TOF mass 
spectrometer (Bio-Rad, Hercules, CA) with a flight path of 0.8 m, capable of mass resolution (m/∆m) of 
1000 and mass accuracy of ± 1000 ppm. Spectra were acquired over the m/z range of 0 to 100 m/z, with 
delayed extraction parameters set to optimally focus the 10- to 20- m/z range. Composite mass spectra are 
the average of 90 laser shots taken from 20 distinct positions across the sample deposit. These positions 
were held constant for all samples used in this study, and 337-nm N2 laser pulse energy was maintained 
just above the threshold for ion production. Mass spectra were externally calibrated using a set of peptide 
and protein calibrants that covered a range of 1 to 66 m/z.  Peptide MALDI-TOF mass spectra were 
acquired using a MALDI-SYNAPT™ MS (Waters, Milford, MA) quadrupole time-of-flight mass 
spectrometer (Q-TOF MS) capable of mass resolution (m/∆m) of 14,000 and a mass accuracy of ± 5 ppm.  
Spectra were acquired over the m/z range of 50 to 2,000 Da.  Composite mass spectra are the result of a 
60 second acquisition with the N2 laser (337-nm) operating at 20 Hz, with the laser pulse energy 
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maintained just above the threshold for ion production. Mass spectra were externally calibrated using 
tandem mass spectrometry (MS/MS) data covering the mass range 70 to 1570 M/z. 
 
Statistical Analysis 
 Differences in mean peak heights and the effects of fungal strain and pigment level on MALDI-
TOF MS data were statistically determined.  Univariate analyses were performed to ensure all data met 
analytic assumptions. Mixed linear models were used to determine if there were differences in the mean 
peak height between concentrations within each strain, between pigment levels across all strains, and 
between strains.  Results were considered significantly different at an alpha level of 0.05. All data were 
analyzed using SAS 9.1 (SAS Institute, Cary, NC). 
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Chapter III 
Results 
 
MALDI Suppression by Darkly Pigmented Fungi 
In the initial studies demonstrating the utilization of MALDI-TOF MS in fungal fingerprinting, 
closely related fungi of several different species belonging to the genera Aspergillus and Penicillium were 
differentiated (64, 65). It was observed that MALDI-TOF MS fingerprinting produced unique spectra for 
each species, and sufficiently allowed for reproducible discrimination between five different isolates of A. 
flavus (64). Unpublished results from additional experiments using different fungi also yielded unique 
spectra. (Figure 2) (92).  
 
 
 
 
 
 
 
 
 
Figure 2: MALDI-TOF MS fingerprint of A) Eurotium amstelodami, B) Penicillium chrysogenum, C) 
Aspergillus versicolor, D) Paecilomyces variotii, E) Curvularia lunata, and F) Chaetomium globosum.  
 
 Despite the utility of MS to differentiate between these monilaceous fungi, several darkly 
pigmented fungi produced spectra with a paucity of peaks, and therefore prevented subsequent 
discriminate differentiation (Figure 3).  
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Figure 3: MALDI-TOF mass spectra of darkly pigmented fungi. A) Alternaria brassicola, B) Alternaria 
alternata, C) Epicoccum nigrum, D) Stachybotrys chartarum, E) Pithomyces chartarum, and F) 
Exserohilum rostratum.  
 
As darkly pigmented fungi are common indoor contaminants that have been implicated in the 
induction and exacerbation of conditions such as asthma and allergies, it was important to obtain a 
MALDI-TOF MS fingerprint of these fungi to demonstrate the utility of this discrimination methodology. 
It was hypothesized that the presence of fungal pigments, such as melanin, in darkly pigmented fungi is 
preventing ionization of the analytes within the sample preparation by an unknown mechanism.  
 
 Synthetic Melanin Suppression of MALDI 
In order to determine if melanin is interfering with the MALDI-TOF MS methodology, different 
concentrations (0.001 mg/mL - 20 mg/mL) of commercially available synthetic melanin were spiked with 
human serum albumin (HSA) and then analyzed via MALDI-TOF MS. The molar concentration of 
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melanin in these solutions cannot be determined from the mass of suspended melanin because melanin is 
a highly disperse polymer, only slightly soluble in the extraction solution, ACN/4% TFA. The MALDI-
TOF mass spectrum of control HSA yields a distribution of peaks corresponding to charge states from 
[M+H]+ to [M+6H]6+ (Figure 4A). Addition of synthetic melanin to the sample deposit results in a 
decrease in peak height in a concentration dependent manner, with the most concentrated melanin 
samples (> 5 mg/mL) completely suppressing HSA peak formation. A concentration of synthetic melanin 
of 0.001 mg/ml spiked with HSA resulted in a 16% decrease (Figure 12). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: MALDI-TOF mass spectra of human serum albumin spiked with synthetic melanin. A) 2X HSA 
only, B) 0.001 mg/ml synthetic melanin + HSA, C) 0.01 mg/ml synthetic melanin + HSA, D) 0.1 mg/ml 
synthetic melanin + HSA, E)1 mg/ml synthetic melanin + HSA, F) 5 mg/ml synthetic melanin + HSA, G) 
10 mg/ml synthetic melanin + HSA, and H) 20 mg/ml synthetic melanin + HSA.  
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Characterization of Isolated Fungal Pigments  
Because the synthetic melanin examined in the preceding experiments is not chemically identical 
to that obtained from fungal sources, fungal pigments were isolated from three different species of 
Aspergillus to determine whether these naturally occurring fungal pigments would also suppress analyte 
[M+H]+ ion formation in MALDI-TOF mass spectra.  Specifically, fungal pigments from Aspergillus 
niger (a black fungus), A. fumigatus (green), and A. terreus (brown) were extracted and characterized 
prior to MALDI-TOF MS analysis. These pigments were chosen to represent the common phenotypical 
colors associated with most fungi, and also because of the ability to fingerprint the lighter pigmented 
fungal samples from A. terreus and A. fumigatus. Figure 5 shows distinguishable spectra derived from A. 
terreus and A. fumigatus; however, samples of A. niger produced spectra that lacked peaks. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 : MALDI-TOF MS fingerprint of fungi using protocol in Hettick et al. 2008 (64, 65). A) A. niger, 
B) A. fumigatus, and C) A. terreus.  
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The pigment preparations were first analyzed and visualized using field emission scanning 
electron microscopy (FESEM). FESEM analysis suggests that fungal pigments isolated from A. niger and 
A. fumigatus maintain the ultrastructural architecture of the fungal spores following melanin extraction 
(Figure 6A-B). This observation is consistent with previous reports of pigments isolated from other fungal 
species, including Cryptococcus neoformans and the term “melanin ghosts” has been coined (91, 93). In 
contrast, pigments extracted from A. terreus were structurally similar to the commercially available 
synthetic melanin (Figure 6 C-D). 
 
BA
DC
 
 
Figure 6: FESEM images of pigment extracts or synthetic melanin. A) A. niger pigment extract, B) A. 
fumigatus pigment extract, C) A. terreus pigment extract, and D) synthetic melanin.  
 
 In addition to the FESEM, elemental analysis was also conducted to determine the chemical 
make-up of each sample because different types of melanins contain different concentrations of carbon, 
nitrogen, hydrogen, and in some cases sulfur. There were no differences between each sample in the 
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chemical components, as each pigment contained high levels of carbon, oxygen, hydrogen, and sulfur, 
while none contained nitrogen (data not shown).  
Gas chromatography/mass spectrometry (GC/MS) was also conducted on each sample to 
determine the presence of different functional groups within each sample. GC/MS analysis indicated the 
presence of long chain fatty acids and aliphatic compounds in each fungal pigment preparation which was 
not present in synthetic melanin (Figure 7A), most likely due to the presence of cell wall components 
within the samples (Figure 7B). These results are consistent with DHN-melanins, which are known to be 
extensively bound to cell wall/structural components of the A. fumigatus spore. 
             
Figure 7: GC/MS spectra of A) Synthetic melanin or B) A. niger pigment extract. The broad peak present 
in B indicates the presence of fatty acid chains and aliphatic compounds. 
 
 In addition, UV spectroscopy was done on each pigment extract. Each pigment (1 mg/mL) 
exhibited strong, non-zero, absorption in the 200-800 nm range when analyzed by UV/VIS spectroscopy, 
and absorption approached 1.0 at 337- nm, the emission wavelength of the nitrogen laser used for 
MALDI-TOF MS. An example of A. niger pigment extract absorption when solubilized in 50/50 
hydrofluoric acid/nitric acid is shown in Figure 8. Pigments from other fungi yielded similar spectra. 
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Figure 8: UV/Vis spectrum of 1 mg/mL A. niger in 50/50 hydrofluoric acid/nitric acid.  
 
This observation is consistent with previous studies that demonstrated melanin to have 
photoprotective properties in fungi, absorbing UV radiation and dissipating energy as heat via rapid 
internal conversion (84-86). Therefore, it is possible that there is competition between the fungal pigment 
and the analytes within the sample, whereby the pigments are absorbing photons, preventing ionization of 
the analytes and subsequently inhibiting the spectrum formation. 
  
Suppression of MALDI-TOF MS by Isolated Fungal Pigments 
  The isolated pigments from each of these fungi were analyzed for protein content before being 
spiked into HSA, none was present. In these experiments, a concentration dependent inhibition of the 
[M+H]+ ion peak height was observed with each fungal pigment extract (Figure 12), similar to that seen 
with synthetic melanin. The most concentrated sample (20 mg/mL) of A. niger pigment reduced the 66 
m/z peak abundance by 96%, while 1 mg/mL of pigment reduced the peak height by 8% (Figures 9 and 
12). A. fumigatus pigment (which did not prevent the acquisition of a unique fingerprint of the fungal 
sample) reduced the peak height by 89% at 20 mg/mL, while the 0.001 mg/mL sample reduced the peak 
height by 10% (Figures 10 and 12). Interestingly, the pigment isolated from A. terreus reduced the HSA 
peak height by 96% at 20 mg/mL and by 8% at 1 mg/mL (Figures 11 and 12), which was unexpected 
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because A. terreus is light brown in color when grown on malt extract agar and the fungi itself produces a 
spectrum that contains multiple peaks of high abundance as shown in Figure 5.  
 
 
 
 
 
 
 
 
 
 
 
Figure 9: MALDI-TOF mass spectra of human serum albumin spiked A. niger pigment preparations. A) 
2X HSA only, B) 0.001 mg/ml A. niger pigment + HSA, C) 0.01 mg/ml A. niger pigment + HSA, D) 0.1 
mg/ml A. niger pigment + HSA, E) 1 mg/ml A. niger pigment + HSA, F) 5 mg/ml A. niger pigment + HSA, 
G) 10 mg/ml A. niger pigment + HSA, and H) 20 mg/ml A. niger pigment + HSA.  
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Figure 10: MALDI-TOF mass spectra of human serum albumin spiked with A. fumigatus pigment 
preparations. A) 2X HSA only, B) 0.001 mg/ml A. fumigatus pigment + HSA, C) 0.01 mg/ml A. fumigatus 
pigment + HSA, D) 0.1 mg/ml A. fumigatus pigment + HSA, E) 1 mg/ml A. fumigatus pigment + HSA, F) 
5 mg/ml A. fumigatus pigment + HSA, G) 10 mg/ml A. fumigatus pigment + HSA, and H) 20 mg/ml A. 
fumigatus pigment + HSA.  
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Figure 11: MALDI-TOF mass spectra of human serum albumin spiked with A. terreus pigment 
preparations. A) 2X HSA only, B) 0.001 mg/ml A. terreus pigment + HSA, C) 0.01 mg/ml A. terreus 
pigment + HSA, D) 0.1 mg/ml A. terreus pigment + HSA, E) 1 mg/ml A. terreus pigment + HSA, F) 5 
mg/ml A. terreus pigment + HSA, G) 10 mg/ml A. terreus pigment + HSA, and H) 20 mg/ml A. terreus 
pigment + HSA.  
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Figure 12: Effect of fungal pigment suppression of 66 m/z HSA peak height.  Data values are reported as 
the mean ± the standard error of measure. 
 
Because melanin is poorly soluble under MALDI sample deposit conditions (e.g. 50/50 ACN/4% 
TFA), the pigment samples analyzed in these experiments were suspensions, not homogenous solutions.  
Further, MALDI sample deposits are often heterogeneous, leading to poor shot-to-shot and deposit-to-
deposit reproducibility (94, 95). Thus, sample deposits used for MALDI-TOF MS analysis which were 
visualized via light microscopy at 4X magnification and appeared heterogeneous, with regions of high 
and low pigment levels across the sample deposit (Figure 13).  
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Figure 13: Light microscopy images of sample spots on a MALDI target chip of A) synthetic melanin, B) 
A. niger pigment extract, C) A. fumigatus pigment extract, and D) A. terreus pigment extract under 4X 
magnification. Equal concentration of each pigment were mixed with matrix and spotted.  
 
This observation may account for the HSA peak height inhibition in those samples. Since the 
synthetic melanin was present more homogenously throughout the spot, as opposed to the aggregated 
pigments from A. niger and A. fumigatus, this presents a greater likelihood that the MALDI UV-laser 
would fire on a spot where pigment was more concentrated. To examine the effect of this heterogeneity 
on the acquired MALDI-TOF mass spectrum, a sample of 10 pmol/µL of angiotensin II was spiked with 
an equal volume of 20 mg/mL A. fumigatus pigment extract and analyzed by high resolution MALDI-
TOF MS (Figure 14). On this instrument, the sample deposit is imaged by a camera and the exact spatial 
location of the MALDI laser output can be guided in real time. Spectra were acquired from regions of 
high and low A. fumigatus pigment concentration (empirically determined by black coloration).  Direct 
suppression of the angiotensin II [M+H]+ ion (1046 m/z) signal in regions of high pigment concentration 
is observed, whereas a strong angiotensin II [M+H]+ ion signal is observed from regions of low pigment 
concentration.  
 35
 
m/z
100 200 300 400 500 600 700 800 900 1000110012001300140015001600170018001900
%
 
Ab
u
n
da
n
ce
0
100
m/z
100 200 300 400 500 600 700 800 900 1000110012001300140015001600170018001900
%
 
Ab
un
da
n
ce
0
100
 
 
Figure 14: MALDI Q-TOF spectra of A. fumigatus pigment extract spiked with 0.5 mg/ml angiotensin II 
(singly charged peak around 1000 m/z) spike with A. fumigatus pigment extract. Top spectrum is taken 
from an area with no visible pigment. Bottom spectrum is taken from a spot with a high concentration of 
pigment extract.  
 
Fungal Culture Conditions Effect Melanin Production 
 The preceding experiments clearly demonstrate that melanin pigments produced by fungi are at 
least, in part, responsible for the observed suppression of MALDI ionization in fingerprint mass spectra 
from darkly pigmented fungi.  Thus, it was further hypothesized that if melanin production could be 
blocked in darkly pigmented fungi, problematic species, such as A. niger, would yield fingerprint mass 
spectra similar to their unmelanized relatives.  Many fungi, when grown for short durations in liquid 
culture, do not produce pigments (29, 81). Thus, melanin-free Aspergillus cultures were produced by 
growing each of the three species in liquid media.  Unique MALDI-TOF MS fingerprint spectra were 
acquired from each fungus grown in liquid culture, including A. niger (Figure 15).  
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Figure 15: MALDI-TOF mass spectra of cultures grown under submerged conditions in malt extract 
broth. A) A. niger, B) A. fumigatus, and C) A. terreus.  
 
The MALDI-TOF mass spectrum for each species grown under submerged conditions contains 
sufficient information to allow these species to be easily discriminated. Contrast the MALDI-TOF 
fingerprint mass spectrum for A. niger grown under submerged conditions (Figure 15A) with that of A. 
niger grown on MEA (Figure 5A). Specifically, five significant peaks were identified, and the replicate 
cultures grouped together and were correctly identified with only a 4% error rate. Two canonical 
functions were used to properly discriminate and group these fungi based predominantly on the peak 
intensity (Figure 16).   
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Figure 16: 2D canonical distribution of fungi grown under submerged culture conditions, n= 8 replicate 
A. niger extracts, f= 8 replicate A. fumigatus extracts, and t= 8 replicate A. terreus extracts.  
 
Inhibition of Melanin Production via Tricyclazole 
Fungi grown in submerged conditions form mycelial masses, a different growth state than 
sporulation, which has been used in previous studies in our laboratory (64, 65). Because fungi grown 
under submerged conditions may contain altered protein concentrations and exhibit significant changes to 
the fingerprint mass spectrum, it makes comparison with sporulating MEA cultures of other Aspergilli 
difficult. Therefore, it was necessary to grow fungi under sporulating conditions and to block melanin 
production to determine if MALDI-TOF MS fingerprint mass spectra could be acquired from these 
species. Therefore, each fungal species was grown under sporulating conditions identical to our 
previously published fungal mass fingerprinting methodology, but in the presence of tricyclazole. 
Tricyclazole is an antifungal agent that specifically inhibits DHN-melanin formation by inhibiting two 
reductases critical to the pentaketide DHN-melanin synthesis pathway (96). Therefore, fungi were grown 
on MEA containing tricyclazole, and then analyzed as above. It is important to note that A. fumigatus, 
when grown on agar containing tricyclazole, appeared light brown in color, similar to A. terreus, 
 38
however, when grown on MEA only, the color of the culture is dark green. Conversely, when A. niger 
was grown under tricyclazole conditions, a significant color change was not noted (Figure 17). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17: Appearance of cultures when grown on MEA only (top) or MEA supplemented with50 µg/mL 
(bottom) for 7 days. A) A. niger grown on MEA, B) A. niger grown on MEA with tricyclazole, C) A. 
fumigatus grown on MEA, D) A. fumigatus grown on MEA with tricyclazole, E) A. terreus grown on 
MEA, and F) A. terreus grown on MEA with tricyclazole.  
 
In general, spectra obtained from cultures grown on agar containing tricyclazole for 14 days 
contained peaks that were of higher abundance than the spectra obtained from samples grown on MEA 
only, despite the difference in phenotypical color not being visibly altered in A. niger or A. terreus. This 
was evident for cultures of A. niger, where peaks were rarely discernable from the background noise of 
the spectra when the fungus was grown on MEA only, however spectra from A. niger grown on agar 
supplemented with tricyclazole five dominant peaks were present, as shown in Figure 18.  
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Figure 18: MALDI-TOF mass spectra of A. niger cultures grown for 7 days (left) or 14 days (right). A) 7 
days  A. niger MEA, B) 7 days A. niger MEA + 1% EtOH, C) 7 days A. niger MEA + 1% EtOH + 50 
µg/ml tricyclazole, D) 14 days A. niger MEA, E) 14 days A. niger MEA + 1% EtOH, and F) 14 days A. 
niger MEA + 1% EtOH + 50 µg/ml tricyclazole.  
 
In addition, spectra from A. terreus and A. fumigatus grown on both MEA and MEA containing 
tricyclazole contained peaks of matching m/z, however, those grown in tricyclazole conditions appeared 
as increased peak intensity (Figures 19 and 20). Peak intensity is an important variable for the ability to 
canonically discriminate between the samples, as shown from the data obtained from the submerged 
culture identification. 
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Figure 19: MALDI-TOF mass spectra of A. fumigatus cultures grown for 7 days (left) or 14 days (right). 
A) 7 days A. fumigatus MEA, B) 7 days A. fumigatus  MEA + 1% EtOH, C) 7 days A. fumigatus MEA + 
1% EtOH + 50 µg/ml tricyclazole, D) 14 days A. fumigatus MEA, E) 14 days A. fumigatus MEA + 1% 
EtOH, and F) A. fumigatus 14 days MEA + 1% EtOH + 50 µg/ml tricyclazole.  
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Figure 20: MALDI-TOF mass spectra of A. terreus cultures grown for 7 days (left) or 14 days (right).  A) 
7 days A. terreus MEA, B) 7 days A. terreus MEA + 1% EtOH,  C) 7 days A. terreus MEA + 1% EtOH + 
50 µg/ml tricyclazole, D) 14 days A. terreus MEA,  E) 14 days A. terreus MEA + 1% EtOH, and F) 14 
days A. terreus MEA + 1% EtOH + 50 µg/ml tricyclazole. 
 
Another variable that was examined was culture time. It was hypothesized that the longer the 
cultures were grown, the more spectra inhibiting melanin would be produced and retained within the 
fungal spore; therefore, fungi grown for a shorter duration would contain less melanin, and thus produce a 
unique fingerprint with discernable peaks. In this series of experiments, cultures were grown for seven 
days under the same conditions as above, and analyzed as previously described. Spectra were obtained 
from each species from MEA only, control MEA with ethanol, and MEA with the addition of tricyclazole 
(Figures 18-20 left). Similar results were obtained from samples that were grown under tricyclazole 
conditions for seven days as were seen for the 14 day culture time. The presence of peaks of similar m/z 
were observed from each spectra, however, the relative abundance of each peak was increased under 
tricyclazole conditions when compared to MEA only. The shorter growth duration, with the presence of 
tricyclazole, did however aid in the visualization of more peaks for A. niger. 
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Chapter IV 
Discussion 
 
 The necessity for rapid identification of microbial organisms for the successful treatment of 
patients with active infections has been shown in multiple studies.  Current identification techniques, such 
as viable culture often require relatively long incubation periods, or have the potential for false-positive or 
false-negative results, as is the case for many current molecular and immunodiagnostic assays. 
Additionally, molecular and immunodiagnostic techniques have the capability to be rapid, however, there 
is a general lack of species-specific primers or monoclonal antibodies (19-24, 31). These techniques are 
used predominantly to detect the presence of a microorganism in a sample, not necessarily the identity, 
which is often required to determine the proper course of treatment. Relatively recently, MALDI-TOF 
MS, a rapid, non-biased, discriminate analytical technique has been shown to be a promising technique 
for fingerprinting microbial species. Specifically, MALDI-TOF MS has been used to identify clinically 
relevant bacteria and viral components, as well as fungi (43-62). Fungi are ubiquitous microorganisms 
capable of causing fatal invasive infections in immunocompromised individuals (1, 2). The successful 
treatment of invasive fungal infections is directly dependent on the rapid identification of the causal 
fungus and subsequent treatment of the patient with appropriate prophylactics (1).   
Though MALDI-TOF MS has shown great promise in the utility of identifying fungi, one 
common problem has been reported by several groups when attempting to fingerprint darkly pigmented 
fungi. Darkly pigmented fungi commonly fail to produce a spectrum containing peaks that allow for their 
discrimination from other fungi (64, 73, 75). Because darkly pigmented fungi have been isolated from 
contaminated indoor environments, and have been implicated in a vast array of diseases, these fungi are 
medically important, and their rapid identification is necessary for the successful treatment of disease. 
Therefore, the purpose of this study was to identify the cause for the inability to fingerprint darkly 
pigmented fungi, and to examine different methods that would allow for the fingerprinting of these 
organisms.  
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One of the many purposes of fungal pigmentation, such as is present in darkly pigmented fungi, is 
to protect the fungus from UV light (77-79); therefore, it was hypothesized that dark fungal pigments 
were preventing the analytes in the MALDI-TOF MS preparation from forming peaks in the spectrum 
potentially by absorbing energy from the UV laser, used to induce ionization of the analyte, during 
MALDI-TOF MS analysis. In order to address this hypothesis, HSA was spiked with synthetic melanin 
and then analyzed for the 66 m/z HSA peak. It was determined that the presence of high concentrations of 
synthetic melanin inhibited the formation of the spectra, as the control HSA only 66 m/z peak height was 
reduced by 100% for concentrated synthetic melanin samples. 
Because the synthetic melanin examined in the preceding experiments is not chemically identical 
to those obtained from fungal sources, fungal pigments from three different species of Aspergillus were 
isolated to determine whether these naturally obtained fungal pigments would also suppress HSA [M+H]+ 
ion formation in MALDI-TOF mass spectra. Fungal pigments were extracted from A. niger, a darkly 
pigmented fungus which was unable to be fingerprinted previously by multiple laboratories, A. fumigatus, 
which contains high concentrations of DHN- melanins yet still formed a unique spectrum. A. terreus, a 
fungus which is light brown when grown under sporulating conditions and also produced a unique 
spectrum. Before MALDI-TOF analysis was conducted with these samples, the pigment extracts were 
characterized. Pigments extracts from A. terreus appeared most like that of the synthetic melanin, whereas 
A. niger and A. fumigatus pigments contained cell wall components and maintained the shape of the 
spores from which they were extracted. In addition, each sample contained similar quantities of carbon, 
hydrogen, nitrogen, and oxygen, while none contained sulfur. This information helped to identify these 
pigments as potential eumelanins, as opposed to phaeomelanins, which contain sulfur (80, 84).  
Furthermore, 1 mg/mL of each pigment exhibited strong absorption in the 200-800 nm range 
when analyzed by UV/VIS spectroscopy. Absorption for each pigment approached 1.0 at 337- nm which 
is the emission wavelength of the nitrogen laser used for MALDI-TOF MS.  This is consistent with 
previous studies that have demonstrated the photoprotective properties of melanin in fungi, whereby 
melanins absorb UV radiation and dissipate this energy as heat via rapid internal conversion (84-86). 
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Although the precise mechanism(s) by which the MALDI desorption/ionization event proceeds remains 
the subject of much discussion and active research (39), it is clear that the unique properties of melanin 
could interfere in a number of fundamental ways with the MALDI process. One plausible explanation for 
the observed inhibition of MALDI-TOF ionization is that melanin in fungal samples (particularly at high 
concentrations) directly competes with the organic acid matrix for irradiating photons. Following the 
MALDI laser pulse, ionization in the dense plume above the sample deposit will only occur where there is 
a sufficient population of electronically excited matrix molecules. If a photoexcitation/pooling mechanism 
for MALDI is assumed (76), mobile excitons in the bulk sample deposit could be quenched by melanin.  
To demonstrate that melanin influences MALDI-TOF MS ionization, HSA was spiked with 
different concentrations of each of these fungal pigment extracts and the 66 m/z peak height was 
analyzed. The presence of pigments from each fungus directly inhibited the 66 m/z peak height formation, 
as greater than 89% of the 66 m/z peak height was inhibited in the most concentrated samples of each 
pigment. Even at 0.001 mg/mL concentration of each pigment, with the exception of A. niger, the HSA 
peak was inhibited by greater than 10%. Surprisingly, the pigment isolated from A. terreus, which 
produces a unique fingerprint spectrum, inhibited HSA peak formation by approximately 23% at the 
lowest concentration. To understand the influence of melanin on the sample spot, sample spots from each 
pigment preparation were visualized by microscopy. The results of these studies demonstrated that the 
pigment in each sample spot was not homogenously distributed. As shown by the FESEM data, the A. 
terreus pigment extract appeared as crystals of pigment and did not maintain the ultrastructural 
morphology of the spore wall as observed with A. fumigatus and A. niger. Therefore, it is possible that the 
pigment extracted from A. terreus was more homogenously distributed throughout the sample spot, and 
that the probability of the 90 laser strikes, which are culminated during each MALDI-TOF MS analysis, 
were present in more of the independent spectra obtained during each laser strike than in those obtained 
from A. fumigatus and A. niger. In order to address the hypothesis that the heterogeneity of the spot would 
alter the mass spectrum, MS equipped with a MALDI source was used to analyze angiotensin II which 
was spiked with A. fumigatus pigment preparation. Using this method, a single spectrum was obtained 
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from an area within the sample spot, as directed by the user. It was determined that the angiotensin II 
peak height was greatly reduced in an area containing visible pigment as opposed to an area within the 
same spot that did not contain pigment. This evidence directly shows the ability of pigment to prevent the 
formation of peaks within a sample. 
In order to determine if darkly pigmented fungi could be fingerprinted if pigmentation was not 
present, several culture techniques were used to produce fungi which lack pigmentation. The first method 
used was by growing the cultures under submerged conditions, during which the fungi do not produce 
pigment. These samples were analyzed and found to produce unique fingerprints which allowed them to 
be discriminated in canonical plots. Discrimination was based on the presence of 5 unique peaks that were 
discernable based on their relative intensities. These growth conditions were not the same as those which 
had been used to acquire previous fingerprinting data, as these conditions induced the formation of 
hyphae, as opposed to sporulation.  
To further explore the influence of demelanizing fungal spores, fungal cultures were grown on 
MEA agar in the presence of tricyclazole, an antifungal agent known to specifically inhibit the formation 
of DHN-melanin. DHN-melanin has been reported to be present in A. fumigatus and potentially A. niger. 
When grown in the presence of tricyclazole, A. fumigatus changes from a dark green color to a light 
brown color, closer to that of A. terreus; however, A. niger did not change color. Despite the difference in 
color changes between the two fungi, the presence of tricyclazole increased the peak intensities for both 
A. fumigatus and A. terreus, but more importantly, resulted in the formation of 2 distinct peaks were 
observed for A. niger. Furthermore, pigmentation increases with the culture age, therefore fungi grown for 
7 days instead of 14 days formed spectra that contained a greater paucity of peaks with higher relative 
abundance than those grown for 14 days under all conditions. In addition, A. niger produced a unique 
fingerprint spectrum at 7 days when grown on MEA only which was not observed in 14 day cultures.  
In conclusion, fungal melanin suppresses peptide and protein ion signals during the acquisition of 
MALDI-TOF mass spectra. Suppression of peptide and protein standard ionization was observed upon 
addition of both commercially available synthetic melanin and melanins purified from three species of 
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Aspergillus to the MALDI sample. Suppression of peptide and protein [M+H]+ ion signals was observed 
at melanin concentrations greater than 500 ng/µL, a concentration significantly less than the level of 
melanin obtained from a fungal culture. Ion suppression occurs in a concentration dependent manner, 
approaching 100% at high melanin concentrations (10 µg/µL). Culture conditions may be manipulated to 
block fungal melanin synthesis and obtain acceptable MALDI-TOF fingerprint mass spectra from darkly 
pigmented species such as A. niger. MALDI-TOF fingerprint mass spectra were acquired from Aspergilli 
grown under liquid culture conditions, as well as cultures grown on malt extract agar supplemented with 
50 µL/mL of tricyclazole, an antifungal agent used to block DHN-melanin synthesis.  
To our knowledge, this is the first report demonstrating the detrimental effects of fungal pigments 
on the acquired MALDI-TOF mass spectrum, as well as the first report of successful fingerprinting of 
darkly pigmented fungi such as A. niger.  This data represents an important step forward for the use of 
MALDI-TOF MS for the rapid identification of darkly pigmented fungi. In addition, these techniques 
may be used to aid in the identification of specific biomarkers for medically important fungi. With the 
identification of species-specific biomarkers via MALDI-TOF MS and subsequent sequencing and 
identification via MS/MS, recombinant proteins based on these biomarkers may be made and used to 
immunize mice for the production of monoclonal antibodies. Those antibodies may be exceptionally 
beneficial in the development of rapid, species-specific immunodiagnostic assays. 
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